drug
aripiprazole ODT
Marketedupdated 6mo agoby Orchid Pharma Inc
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying aripiprazole ODT
- phase4A Phase 4 Study to Assess the Effects of Aripiprazole Versus Other Atypical Antipsychotics in the Treatment of Schizophrenic Patients With Metabolic Syndrome
- phase3Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Symptoms of Schizophrenia and to Evaluate the Relapse Rate of Roluperidone and Antipsychotic Medications
- phase2A Study Assessing the Efficacy and Safety of HS-10380 in Hospitalized Adults With Acute Schizophrenia
- N/ASteady-state Bioequivalence Study of Aripiprazole for Injection in Patients With Schizophrenia.
- —Long-term Antipsychotic Pediatric Safety Trial
- phase4C-Cog in Early Course Schizophrenia Study
- phase1Whole Blood and Plasma Sample Collection for the Development of Antipsychotic Immunoassays From Participants Taking Aripiprazole, Olanzapine, Paliperidone, or Risperidone
- phase2RP5063 in Subjects With Schizophrenia or Schizoaffective Disorder
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 4h ago
Found something off?
comments(0)
5-min edit window · permanent after that